Is BrightSpring Health Services, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for BrightSpring Health Services, Inc. moved from expensive to attractive, indicating a shift towards being undervalued. The company appears to be undervalued based on several key ratios, including a P/E ratio of 37, an EV to EBITDA of 12.65, and a PEG ratio of 0.12, which suggests strong growth potential relative to its price.
In comparison to its peers, BrightSpring's P/E ratio of 37.784 is slightly higher than the industry average, while its EV to EBITDA of 13.2063 is more favorable, indicating better valuation metrics. Notably, the company has outperformed the S&P 500 with a year-to-date return of 74.57% compared to the index's 13.30%, reinforcing the attractiveness of its current valuation.